Results 171 to 180 of about 2,076,544 (288)

Helicobacter pylori, Betel Quid Chewing, and Endoscopic Pathology in Dyspeptic Patients: A Cross‐Sectional Analytical Study

open access: yesPublic Health Challenges, Volume 5, Issue 4, December 2026.
In dyspeptic patients, Helicobacter pylori infection and betel quid chewing showed graded but non‐significant associations with endoscopic pathology, with their joint effect suggesting additivity rather than synergy. Longer betel quid chewing and tobacco use showed suggestive dose–response associations.
Mostak Uddin Ahmed   +8 more
wiley   +1 more source

Comprehensive and reproducible grading of the Updated Sydney System in gastric biopsies using artificial intelligence: multi‐pathologist validation and a reader study

open access: yesHistopathology, Volume 89, Issue 6, Page 1042-1055, December 2026.
SydneyMTL is an interpretable multi‐task model providing four‐level grading for the five Sydney System attributes. By significantly improving diagnostic concordance and reducing reading time, it offers a robust clinical tool to alleviate pathologist workloads and standardize routine gastric biopsy screening.
Ho Heon Kim   +5 more
wiley   +1 more source

Research Progress on the Efficacy and Mechanism of Acupuncture in Treating Chronic Gastritis. [PDF]

open access: yesDiseases
He J   +9 more
europepmc   +1 more source

Real‐World Longitudinal Data on the Impact of Hydroxychloroquine Blood Level Monitoring on Lupus Outcomes: Results of a Prospective Longitudinal Cohort Study

open access: yesArthritis Care &Research, Volume 78, Issue 11, Page 1618-1630, November 2026.
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel   +6 more
wiley   +1 more source

Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthma

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3819-3830, November 2026.
Abstract Aim Tezepelumab is a human monoclonal antibody that blocks the activity of thymic stromal lymphopoietin and is approved for adolescents and adults with severe asthma. This analysis assessed pharmacokinetics (PK), pharmacodynamics and safety of tezepelumab up to 85 days postdose in adolescents and children.
Anna Lundahl   +14 more
wiley   +1 more source

Correction: Integrative analysis of serum lipids and chronic gastritis: causal insights from mendelian randomization and experimental models. [PDF]

open access: yesLipids Health Dis
Chu X   +11 more
europepmc   +1 more source

Plasma IFNL3 for Gastric Cancer Detection and Monitoring in East Asians: A Multiphase Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Gastric cancer (GC) has a high incidence in East Asia, yet early detection remains limited. Methods In this multiphase study, 395 participants (96 GC, 72 precancerous lesions, 227 healthy donors) were enrolled. Plasma IFNL3 levels were measured using ELISA.
Yunmeng Nie   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy